Phase 3 × Completed × Lymphoma, Large B-Cell, Diffuse × Clear all BELINDA
Phase 3 Completed
330 enrolled 10 charts
DEB
Phase 3 Completed
423 enrolled
EVAPOR
Phase 3 Completed
26 enrolled
POLARGO
Phase 3 Completed
270 enrolled 36 charts
ZUMA-7
Phase 3 Completed
359 enrolled 27 charts
Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma
Phase 3 Completed
700 enrolled 21 charts
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
Phase 3 Completed
838 enrolled 16 charts
Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1â„¢
Phase 3 Completed
256 enrolled 9 charts
Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
Phase 3 Completed
A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL
Phase 3 Completed
421 enrolled
MADILYM
Phase 3 Completed
143 enrolled 25 charts
Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
Phase 3 Completed
849 enrolled 13 charts
ROBUST
Phase 3 Completed
570 enrolled 27 charts
Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
Phase 3 Completed
40 enrolled
PIX-R
Phase 3 Completed
312 enrolled 16 charts
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer
Phase 3 Completed
250 enrolled 10 charts
REMARC
Phase 3 Completed
650 enrolled
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Phase 3 Completed
1,506 enrolled
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
Phase 3 Completed
392 enrolled
Efficacy of Lenalidomide in Combination With Subcutaneous Rituximab + miniCHOP in DLBCL Patients of 80 y/o or+
Phase 3 Completed
250 enrolled
Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Phase 3 Completed
592 enrolled
SWOG-9704 Chemoradiotherapy and Peripheral Stem Cell Transplantation Compared With Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma
Phase 3 Completed
397 enrolled 14 charts
SPARKLE
Phase 3 Completed
166 enrolled
A Study Comparing the Efficacy and Safety Between I-CHOP and R-CHOP in Untreated CD20-Positive Diffuse Large B-cell Lymphoma Patients
Phase 3 Completed
420 enrolled
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Phase 3 Completed
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Phase 3 Completed
14 enrolled
Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial
Phase 3 Completed
583 enrolled
Treatment for Chronic Pain in Patients With Advanced Cancer
Phase 3 Completed
87 enrolled
IDEC-C2B8
Phase 3 Completed
824 enrolled
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Phase 3 Completed
174 enrolled 12 charts
Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma
Phase 3 Completed
272 enrolled 20 charts
R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma
Phase 3 Completed
481 enrolled
Combination Chemotherapy in Treating Patients With Lymphoma
Phase 3 Completed
116 enrolled
Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma
Phase 3 Completed
61 enrolled
Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma
Phase 3 Completed
122 enrolled 9 charts
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a
Phase 3 Completed
743 enrolled 16 charts
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
Phase 3 Completed
572 enrolled 14 charts
Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.
Phase 3 Completed
246 enrolled 13 charts
PILLAR2
Phase 3 Completed
742 enrolled 10 charts
Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Phase 3 Completed
87 enrolled 16 charts
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
Phase 3 Completed
164 enrolled 8 charts
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Phase 3 Completed
364 enrolled 29 charts
Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
Phase 3 Completed
472 enrolled
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
Phase 3 Completed
100 enrolled
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
Phase 3 Completed
683 enrolled
REMoDL-B
Phase 3 Completed
1,132 enrolled
R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma
Phase 3 Completed
600 enrolled
ORCHARRD
Phase 3 Completed
447 enrolled 21 charts
Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
Phase 3 Completed
50 enrolled
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
Phase 3 Completed
242 enrolled